Information about a number of Pneumocystis carinii lipids obtained by
the analyses of organisms isolated and purified from infected lungs of
corticosteroid-immunosuppressed rats has been reported in recent year
s. Of the common opportunistic protists associated with AIDS (Cryptosp
oridium, Toxoplasma, and the microsporidia), more is currently known a
bout the lipids of P. carinii than the others. Lipids that are synthes
ized by the organism but not by humans are attractive targets for drug
development. thus, the elucidation of Delta(7)C-24-alkylated sterol a
nd cis-9,10-epoxystearic acid biosyntheses in P. carinii is currently
being examined in detail, since these have been identified as P. carin
ii-specific lipids. the development of low-toxicity drugs that prevent
sterol C-24 alkylation and the specific inhibition of the lipoxygenas
e that forms cis-9,10-epoxystearic acid might prove fruitful. Although
humans can synthesize coenzyme Q(10) the anti-P. carinii activity and
low toxicity of ubiquinone analogs such as atovaquone suggest that th
e electron transport chain in the pathogen may differ importantly from
that in the host. Although resistance to atovaquone has been observed
, development of other naphthoquinone drugs would provide a broader ar
mamentarium of drugs to treat patients.